Investor relations

With the marketing approval for Sedaconda (isoflurane) in 15 EU countries and a great interest in inhaled sedation and our products, Sedana Medical is well-positioned for the future.

We are well on the way to the vision of making inhaled sedation a standard therapy in critical care.

The Share

See More

Press Releases

Bulletin from the annual general meeting in Sedana Medical AB (publ)


Today, the annual general meeting of Sedana Medical AB (publ) (SEDANA: FN Stockholm) was held. In or…

Sedana Medical AB Interim report January-March 2022


First patient enrolled in US clinical program

Sedana Medical announces enrolment of first patient in US clinical program


Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announces that the first patient has been enro…

View All Press Releases

Financial Calendar

Handelsbanken Nordic MidSmall Cap Seminar 08 June 2022 09:10
Interim report Q2 2022 21 July 2022 07:00

See More